PA
DGX icon

Pinnacle Associates’s Quest Diagnostics DGX Stock Holding History

Pinnacle Associates’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.51M Buy
12,825
+23
+0.2% +$4.47K 0.03% 362
2025
Q4 		$2.22M Buy
12,802
+115
+0.9% +$20.9K 0.03% 382
2025
Q3 		$2.42M Buy
12,687
+401
+3% +$71.2K 0.03% 361
2025
Q2 		$2.21M Sell
12,286
-364
-3% -$63.2K 0.03% 366
2025
Q1 		$2.14M Buy
12,650
+465
+4% +$76.4K 0.03% 367
2024
Q4 		$1.84M Buy
12,185
+183
+2% +$28.5K 0.02% 378
2024
Q3 		$1.65M Sell
12,002
-50
-0.4% -$7.47K 0.03% 383
2024
Q2 		$1.65M Buy
12,052
+158
+1% +$21.6K 0.03% 396
2024
Q1 		$1.58M Sell
11,894
-108
-0.9% -$14K 0.03% 409
2023
Q4 		$1.65M Buy
12,002
+69
+0.6% +$9.07K 0.03% 388
2023
Q3 		$1.45M Sell
11,933
-335
-3% -$44.6K 0.03% 399
2023
Q2 		$1.72M Buy
12,268
+215
+2% +$29.6K 0.03% 379
2023
Q1 		$1.71M Sell
12,053
-48
-0.4% -$6.87K 0.03% 324
2022
Q4 		$1.89M Buy
12,101
+12
+0.1% +$1.72K 0.04% 311
2022
Q3 		$1.48M Buy
12,089
+134
+1% +$17.6K 0.03% 328
2022
Q2 		$1.59M Sell
11,955
-311
-3% -$42.4K 0.03% 331
2022
Q1 		$1.68M Buy
12,266
+4
+0% +$558 0.03% 364
2021
Q4 		$2.12M Sell
12,262
-21
-0.2% -$3.19K 0.04% 339
2021
Q3 		$1.78M Sell
12,283
-21
-0.2% -$3.07K 0.03% 357
2021
Q2 		$1.62M Buy
12,304
+404
+3% +$52.9K 0.03% 363
2021
Q1 		$1.53M Sell
11,900
-84
-0.7% -$10.4K 0.03% 364
2020
Q4 		$1.43M Sell
11,984
-1,680
-12% -$205K 0.03% 348
2020
Q3 		$1.56M Buy
13,664
+716
+6% +$84.6K 0.04% 312
2020
Q2 		$1.48M Buy
12,948
+5
+0% +$530 0.04% 314
2020
Q1 		$1.04M Sell
12,943
-750
-5% -$77.6K 0.03% 328
2019
Q4 		$1.46M Buy
13,693
+729
+6% +$76K 0.03% 344
2019
Q3 		$1.39M Sell
12,964
-249
-2% -$25.6K 0.03% 353
2019
Q2 		$1.34M Sell
13,213
-96
-0.7% -$9.22K 0.03% 355
2019
Q1 		$1.2M Sell
13,309
-245
-2% -$21.2K 0.03% 378
2018
Q4 		$1.13M Buy
13,554
+216
+2% +$20.3K 0.03% 375
2018
Q3 		$1.44M Sell
13,338
-1,033
-7% -$113K 0.03% 359
2018
Q2 		$1.58M Sell
14,371
-196
-1% -$20.4K 0.03% 343
2018
Q1 		$1.46M Sell
14,567
-8,270
-36% -$847K 0.03% 352
2017
Q4 		$2.25M Sell
22,837
-1,896
-8% -$180K 0.04% 289
2017
Q3 		$2.32M Buy
24,733
+171
+0.7% +$18.2K 0.04% 288
2017
Q2 		$2.73M Sell
24,562
-196
-0.8% -$20.7K 0.05% 270
2017
Q1 		$2.43M Buy
24,758
+377
+2% +$35.9K 0.05% 291
2016
Q4 		$2.24M Sell
24,381
-17,497
-42% -$1.51M 0.05% 293
2016
Q3 		$3.54M Sell
41,878
-126
-0.3% -$10.6K 0.07% 238
2016
Q2 		$3.42M Buy
42,004
+238
+0.6% +$18.1K 0.07% 239
2016
Q1 		$2.98M Sell
41,766
-1,220
-3% -$81.8K 0.06% 244
2015
Q4 		$3.06M Sell
42,986
-833
-2% -$56K 0.06% 240
2015
Q3 		$2.69M Sell
43,819
-538
-1% -$37.6K 0.06% 256
2015
Q2 		$3.22M Buy
44,357
+182
+0.4% +$13.4K 0.06% 244
2015
Q1 		$3.4M Sell
44,175
-343
-0.8% -$24.6K 0.06% 232
2014
Q4 		$2.98M Buy
44,518
+417
+0.9% +$26.3K 0.06% 246
2014
Q3 		$2.68M Sell
44,101
-193
-0.4% -$11.9K 0.05% 255
2014
Q2 		$2.6M Buy
44,294
+21,364
+93% +$1.25M 0.05% 257
2014
Q1 		$1.33M Buy
22,930
+2,250
+11% +$121K 0.03% 318
2013
Q4 		$1.11M Buy
20,680
+622
+3% +$36.9K 0.02% 347
2013
Q3 		$1.24M Buy
20,058
+12,615
+169% +$755K 0.03% 325
2013
Q2 		$451K Buy
+7,443
New +$443K 0.01% 433

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Pinnacle Associates's DGX Position: Q1 2026 in Review

Pinnacle Associates increased its Quest Diagnostics (DGX) stake by 0.18% in Q1 2026, buying an estimated $4.47K and bringing the position to 12,825 shares worth $2.51M. The position accounts for 0.03% of the portfolio, ranked #362.

Pinnacle Associates first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.54M in Q3 2016. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Pinnacle Associates held 12,825 shares of Quest Diagnostics worth $2.51M as of Q1 2026.
  • Pinnacle Associates bought 23 Quest Diagnostics shares in Q1 2026, an estimated $4.47K.
  • Quest Diagnostics made up 0.03% of Pinnacle Associates's portfolio in Q1 2026, its #362 holding.
  • Pinnacle Associates first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's Quest Diagnostics position peaked at $3.54M in Q3 2016.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.